Application 050294
- Type
- BLA
- Sponsor
- PARKE DAVIS
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 050294 | Elase-chloromycetin | fibrinolysin and desoxyribonuclease combined [bovine], with chloramphenicol | 351(a) | Disc | 2026-09-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ELASE-CHLOROMYCETIN | CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN | OINTMENT;TOPICAL | 10MG/GM;666 UNITS/GM;1 UNITS/GM | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 62259 | APPL | 2020-03-23 |